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Abstract
Background: Offloading interventions are commonly used in clinical practice to heal
foot ulcers. The aim of this updated systematic review is to investigate the effective-
ness of offloading interventions to heal diabetic foot ulcers.
Methods: We updated our previous systematic review search of PubMed, EMBASE,
and Cochrane databases to also include original studies published between July
29, 2014 and August 13, 2018 relating to four offloading intervention categories in
populations with diabetic foot ulcers: (a) offloading devices, (b) footwear, (c) other
offloading techniques, and (d) surgical offloading techniques. Outcomes included
ulcer healing, plantar pressure, ambulatory activity, adherence, adverse events,
patient-reported measures, and cost-effectiveness. Included controlled studies
were assessed for methodological quality and had key data extracted into evidence
and risk of bias tables. Included non-controlled studies were summarised on a nar-
rative basis.
Results:We identified 41 studies from our updated search for a total of 165 included
studies. Six included studies were meta-analyses, 26 randomised controlled trials
(RCTs), 13 other controlled studies, and 120 non-controlled studies. Five meta-
analyses and 12 RCTs provided high-quality evidence for non-removable knee-high
Abbreviations: DFU, diabetic foot ulcer; IWGDF, International Working Group on the Diabetic Foot; PICOs, population, intervention, control, outcomes; PRISMA, preferred reporting items for
systematic reviews and meta-analyses; RCT, randomised controlled trial; SIGN, Scottish Intercollegiate Grouping Network.
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offloading devices being more effective than removable offloading devices and thera-
peutic footwear for healing plantar forefoot and midfoot ulcers. Total contact casts
(TCCs) and non-removable knee-high walkers were shown to be equally effective.
Moderate-quality evidence exists for removable knee-high and ankle-high offloading
devices being equally effective in healing, but knee-high devices have a larger effect
on reducing plantar pressure and ambulatory activity. Low-quality evidence exists for
the use of felted foam and surgical offloading to promote healing of plantar forefoot
and midfoot ulcers. Very limited evidence exists for the efficacy of any offloading
intervention for healing plantar heel ulcers, non-plantar ulcers, and neuropathic ulcers
with infection or ischemia.
Conclusion: Strong evidence supports the use of non-removable knee-high
offloading devices (either TCC or non-removable walker) as the first-choice
offloading intervention for healing plantar neuropathic forefoot and midfoot ulcers.
Removable offloading devices, either knee-high or ankle-high, are preferred as sec-
ond choice over other offloading interventions. The evidence bases to support any
other offloading intervention is still weak and more high-quality controlled studies
are needed in these areas.
K E YWORD S
diabetes mellitus, diabetic foot, foot ulcer, footwear, offloading, off-loading, offloading device,
pressure, surgery, systematic review
1 | INTRODUCTION
Diabetic foot ulcers (DFUs) are a leading global cause of amputation,
hospitalisation, and disability.1-5 Around 26 million people worldwide
annually have a DFU with another 130 million at risk with diabetic
peripheral neuropathy.4,5
The most common pathway to a DFU is via excessive mechanical
stress on an insensate foot.5-9 Mechanical stress is an accumulation of
the effects of plantar pressure, shear stress, and ambulatory activity
over time.5-9 If excessive, mechanical stress results in inflammation,
DFU development, and prolonged DFU healing, which in turn
increases the risk of infection, hospitalisation, and amputation.5-9
Reducing excessive mechanical stress using offloading interventions is
considered the cornerstone of treatment for neuropathic DFU.1,5-10
Offloading interventions typically include offloading devices, foot-
wear, surgical procedures, and other techniques such as felted
foam.8,9,11
In 2016, we published a systematic review into the effectiveness
of these offloading interventions to heal DFUs.11 Since then, a num-
ber of meta-analyses12-15 and well-designed controlled trials16-19 have
been published that add to the evidence base. Thus, the aim of this
systematic review is to update our previous systematic review investi-
gating the effectiveness of offloading interventions to heal foot ulcers
in people with diabetes.11 The findings will also be used to support
the International Working Group on the Diabetic Foot (IWGDF)
guideline on offloading interventions to heal foot ulcers in persons
with diabetes.20
2 | METHODS
This systematic review was performed in accordance with the pre-
ferred reporting item for systematic reviews and meta-analyses
(PRISMA) guidelines21,22 and was prospectively registered in the
PROSPERO database for systematic reviews (CRD42018105681).
The population (P), interventions (I), controls (C), and outcomes (O) of
interest were initially defined and pertinent clinical questions (PICOs)
formulated by the authors. These definitions and clinical questions
were subsequently reviewed and approved by the IWGDF Editorial
Board and 10 external experts from diverse global geographic regions.
All clinical questions can be found within this paper and all definitions
can be found in accompanying IWGDF publications.20,23,24
2.1 | Eligibility criteria
To be included, studies had to include an eligible population, interven-
tion, outcome, and design.
2.1.1 | Population
The population of interest for this review were people with a DFU,
defined as any full thickness lesion below the malleoli associated with
peripheral neuropathy and/or peripheral artery disease in people with
diabetes.20,23,24 People at-risk of DFU were also eligible if they were
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specifically being used as a “surrogate DFU population” to test
offloading interventions for potential offloading effectiveness in a
future DFU population. Those at-risk were defined as people with dia-
betes and previous DFU, peripheral neuropathy, or peripheral arterial
disease.20,23,24
2.1.2 | Interventions
Offloading interventions were defined as any intervention undertaken
with the intention of relieving mechanical stress from a specific region
of the foot.20,23,24 They were grouped into four categories typically
used in clinical practice as follows:
1. Offloading devices. Any offloading intervention that was a custom-
made or prefabricated device, excluding footwear.20 Offloading
devices were further subcategorised into non-removable or
removable and knee-high or ankle-high devices.20
2. Footwear. Any offloading intervention that was shoe-gear, includ-
ing insoles and socks.20 Footwear was further subcategorised into
conventional and therapeutic footwear.20
3. Other offloading techniques. Any other non-surgical offloading
intervention that was not an offloading device or footwear.20
4. Surgical offloading techniques. Any offloading intervention that was
a surgical procedure or technique.20
2.1.3 | Outcomes
Primary, surrogate, and secondary outcomes of interest were included
in this review. In brief, the primary outcome was a healed DFU, typi-
cally defined by studies as complete epithelialization.20,23,24
Surrogate outcomes were changes in plantar pressure, ulcer area,
ambulatory activity, and adherence.20,23,24 Plantar pressure was typi-
cally defined by studies as peak plantar pressure or peak pressure time
integral.20,23,24 Ulcer area was typically defined as ulcer surface
area.20,24 Ambulatory activity was typically defined as average num-
ber of daily steps.20,24 Adherence was typically defined as the propor-
tion of total time or total steps during which the offloading
intervention was used.20,24
Secondary outcomes included adverse events, patient-reported
outcome measures (PROMs), and cost-effectiveness.20,24 Adverse
events were typically defined as complications related to the interven-
tion.20,24 PROMs were typically defined through validated patient
self-reporting tools, including quality of life, satisfaction, or prefer-
ence.20,24 Cost-effectiveness was typically defined as the degree to
which the intervention was effective in relation to cost.20,24
2.1.4 | Designs
Eligible study designs included systematic reviews and meta-analyses,
randomised controlled trials (RCTs), nonrandomised controlled trials
(NRCTs), cohort studies, case-control studies, within-subject repeated
measures studies, interrupted time series, non-controlled prospective
or retrospective studies, cross-sectional studies, and case series. Case
studies, commentaries, and published conference abstracts were not
eligible. Any systematic review that included the exact same papers as
identified by our systematic search was excluded, unless they under-
took a meta-analysis.
2.2 | Search strategy
2.2.1 | Validation set
A validation set of 30 publications was created,8,12,13,15-19,25-46 includ-
ing key studies known to the authors published since our previous
search (July 29, 2014).11 Using this set, the search strings used were
validated; ie, each publication had to be identified before the search
strings were used in this systematic review.
2.2.2 | Search
The search was performed on August 13, 2018 and included stud-
ies in any language that were published since July 29, 2014. The
following databases were searched: PubMed, EMBASE and
the Cochrane Library Databases for Cochrane Reviews, Cochrane
Protocols and Trials. We did not use CINAHL this time as it did
not identify any additional relevant papers in our last review.11
For each search string, the population was added to each of the
four offloading intervention categories and produced results for
the four categories for each database. The search strings for each
database are shown in Appendices 1 to 3.
2.2.3 | Eligibility assessment
Two authors independently screened records by title and abstract for
eligibility based on the four defined criteria: population, intervention,
outcome, and design. Cohen's kappa was calculated for agreement
between authors. Any disagreements were then discussed between
authors until consensus was reached. If this was not possible, a third
author decided. All records deemed eligible were included for full text
assessment.
Two authors then independently assessed all included full text
records for inclusion based on the same four criteria. Any papers
not in the English language were translated to English via
Onlinedoctranslator.47 Any disagreements on inclusion were dis-
cussed until consensus was reached. If this was not possible, a third
author decided. If an author was a co-author of the full text, another
author replaced that author for assessment. All full text records
remaining eligible were included in this review. We used the online
application Rayyan to assist with these eligibility assessment
processes.48
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2.3 | Qualitative assessments
All included studies were assessed for study design, methodological
quality, level of evidence, and key data were extracted.
2.3.1 | Study design assessment
Two authors jointly classified the study design of all included studies
using the SIGN algorithm for classifying study design (http://www.
sign.ac.uk/pdf/studydesign.pdf). Studies classified as being a meta-
analysis or of controlled study design (RCT, controlled cohort, case-
control studies) were assessed for methodological quality and had key
data extracted. Studies classified as being a non-controlled design
were narratively described if no controlled studies were identified that
addressed the clinical question or if the non-controlled studies added
relevant evidence.
2.3.2 | Methodological quality assessment
Two authors independently assessed each included study deemed to
be a meta-analysis or controlled study design for methodological qual-
ity (ie, risk of bias). For meta-analyses, this was performed using the
12-item SIGN methodology checklist for systematic reviews and
meta-analyses tool (https://www.sign.ac.uk/checklists-and-notes.
html). For controlled studies, this was performed using one of two
Dutch Cochrane Centre quality assessment tools: a 10-item tool for
RCTs or a 10-item tool for cohort studies (www.cochrane.nl). Addi-
tionally, for all controlled studies, the 21-item IWGDF quality assess-
ment tool on reporting standards for diabetic foot studies was used.24
Any disagreements were discussed until consensus was reached. If
this was not possible, a third author decided. If an author was a co-
author of the included study, another author replaced that author for
assessment.
2.3.3 | Level of evidence assessment
For each controlled study, two authors jointly used the study design
and methodological quality assessments to determine its level of evi-
dence. Level 1 evidence referred to meta-analyses, systematic
reviews, or RCTs. Level 2 evidence referred to NRCTs, cohort, case-
control, or interrupted time series studies. Risk of bias was then
scored using the total methodological quality assessment score
obtained from the respective SIGN or Dutch Cochrane Centre tools
as follows: ++ (very low risk of bias) for any meta-analyses scoring
greater than or equal to 10/12, or any controlled study scoring greater
than or equal to 8/10; + (low risk of bias) for any meta-analyses scor-
ing a 7 to 9/12, or any controlled study scoring 6 to 7/10; and - (high
risk of bias) for any meta-analyses scoring less than or equal to 6/12,
or any controlled study scoring less than or equal to 5/10. Equal
weighting was applied to each item in the SIGN or Dutch Cochrane
Centre tools. All non-controlled studies were automatically deemed as
Level 3 evidence and not assessed for risk of bias.
2.3.4 | Data extraction assessment
Key data were extracted for each meta-analysis and controlled study
and summarised in evidence tables. One author extracted all data, and
a second author checked the accuracy of data entry. Data extracted
included intervention category, outcomes reported, study design, set-
ting, population, intervention and control characteristics, follow-up
period, and key findings. The risk of bias and level of evidence scores
were also entered into the evidence tables. All authors discussed the
evidence tables until consensus was reached on accuracy.
2.4 | Previously included studies
Our previous systematic review included some eligibility criteria not
used in this updated review, including populations at risk of DFU, if
offloading interventions were tested to prevent DFU, and outcomes
of DFU incidence.11 Thus, all previously included studies were
reassessed by one author and checked by another to ensure eligibility.
Any studies deemed not eligible for this review were excluded.
All previously included studies that remained eligible had their
methodological quality and data extraction item assessments from our
previous review used for this updated review and entered into the
evidence tables. Any additional items not included in the previous
review were assessed for as per methods described above.
2.5 | Evidence statements
Finally, for each clinical question, two or more authors jointly drafted
a summary of the evidence. The summary of the evidence was primar-
ily based on the strength of all available meta-analyses and controlled
study evidence from the completed evidence tables for the clinical
question concerned. Evidence from non-controlled studies was only
used if it added relevant evidence.
Two authors then formulated a concluding evidence statement(s)
to address each clinical question according to the GRADE system.49
However, if there was no controlled study or relevant non-controlled
study evidence to address the question, then no evidence statement
was formulated.
The authors rated the quality of the evidence (QoE) for each for-
mulated evidence statement as “high,” “moderate,” or “low.”50,51 A
high QoE rating was defined as “further research was unlikely to
change our confidence in our evidence statement.”50,51 A moderate
QoE rating was defined as “further research was likely to have an
impact on our confidence in our evidence statement.”50,51 A low QoE
rating was defined as “further research was very likely to have an
impact on our confidence in our evidence statement.”50,51 Evidence
statements supported by Level 1 evidence automatically started as a
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high QoE rating, but this could be reduced if studies had high risk of
bias, inconsistent results across studies, or publication bias was pre-
sent.50,51 Conversely, evidence statements supported by Level 2 evi-
dence started as a low QoE rating, but this could be increased if
studies had a large effect size or clear evidence of a dose-response
relationship.50,51 All members of the working group discussed these
evidence statements and QoE ratings until consensus was reached.
3 | RESULTS
Figure 1 displays the PRISMA flowchart. Our updated search since
July 29, 2014 identified a total of 3715 records. After screening,
152 records remained for full-text assessment. Screening agreement
between authors was low to very high (Cohen's kappa: 0.16 to 0.80).
After full-text assessment, 41 studies published since July 29, 2014
were included. Additionally, after full text re-assessment of the
176 included studies from our previous review, 124 studies published
before July 29, 2014 remained included. Thus, a total of 165 studies
were included for this review, including six meta-analyses, 26 RCTs,
13 other controlled studies, and 120 non-controlled studies.
Tables 1–3 display the risk of bias tables for all included meta-
analyses, RCTs, and other controlled studies by each offloading inter-
vention category, respectively. Appendices 4 to 6 display the evidence
tables for all included meta-analyses, RCTs, and other controlled stud-
ies by each offloading intervention category, respectively. Summaries
of the evidence, evidence statements and quality of evidence for each
clinical question addressing the primary outcome of DFU healing and
the surrogate outcome of plantar pressure can be found below. Sum-
maries of the evidence, evidence statements and quality of evidence
for each clinical question addressing all other surrogate or secondary
outcomes can be found in Appendices 7 and 8. Table 4 summarises all
evidence statements with accompanying quality of evidence rating for
each predefined clinical question.
F IGURE 1 Preferred reporting items for systematic reviews and meta-analyses flow diagram
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TABLE 4 Evidence statements from systematic review for offloading interventions to heal neuropathic plantar forefoot or midfoot ulcers in
patients with diabetes, unless otherwise stateda
Outcome Evidence Statement Qualityb References
PRIMARY: Healing
Nonremovable offloading device Nonremovable knee-high offloading devices are
more effective than removable offloading
devices to heal the DFU.
High Health Quality Ontario 2017,12
Elraiyah et al 2016,13 Martins de
Oliveira and Moore 2015,15
Morona et al 2013,53 and Lewis
and Lipp 201352
TCCs and non-removable knee-high walkers are
equally effective to heal the DFU.
Moderate Health Quality Ontario 2017,12
Morona et al 2013,53 and Miyan
et al 201436
Removable offloading device Removable knee-high offloading devices and
removable ankle-high offloading devices are
equally effective to heal the DFU.
Moderate Health Quality Ontario 201712 and
Bus et al 201816
Footwear Therapeutic footwear is less effective than non-
removable knee-high offloading devices to heal
the DFU.
Moderate Health Quality Ontario 2017,12
Elraiyah et al 2016,13 Morona
et al 2013,53 and Miyan
et al 201436
Other offloading technique Felted foam (with an aperture cut to the DFU
location) attached to either the foot or the insole
in a removable ankle-high offloading device
seems to be more effective to heal the DFU than
only wearing a removable ankle-high offloading
device.
Low Zimny et al 200368 and Birke
et al 200277
Surgical offloading technique Achilles tendon lengthening in addition to a non-
removable offloading device seems equally
effective to heal the DFU as a non-removable
offloading device alone
Low Dallimore and Kaminski 201514
Metatarsal head resection(s) in combination with a
removable offloading device seems more
effective to heal a neuropathic plantar metatarsal
head DFU than using a removable offloading
device alonea
Low Kalantar Motamedi et al 2017,80
Armstrong et al 2012,82 Armstrong
et al 2005,61 and Piaggesi et al
199872
Medial column arthrodesis in combination with a
non-removable offloading device is not superior
in healing a neuropathic plantar midfoot DFU
associated with a Charcot deformity than using a
non-removable offloading device alonea
Low Wang et al 201569
First metatarsal-phalangeal joint arthroplasty in
combination with non-removable offloading
device may lead to shorter time-to-healing a
neuropathic plantar hallux DFU than using a
non-removable offloading device alonea
Low Armstrong et al 200384 and Lin et al
200085
Osteotomy seems more effective to heal a
metatarsal head DFU than conservative
treatment (with or without offloading) alone
Low Vanlerberghe et al 201481
Digital flexor tenotomy seems effective to heal a
neuropathic plantar lesser digit apical DFU, but
evidence from controlled studies is needed to
confirm thisa
Low Engels et al 2016,86 Tamir et al
2014,87 Rasmussen et al 2013,88
van Netten et al 2013,89 Kearney
et al 2010,90 Schepers et al
2010,91 Tamir et al 2008,92 and
Laborde et al 200793
Other DFU types Nonremovable knee-high offloading devices seem
effective to heal a neuropathic plantar forefoot
DFU complicated by either mild infection or mild
ischaemiaa
Low Ha Van et al 201576 and Nabuurs-
Franssen et al 200594
Low Ganguly et al 200857
(Continues)
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TABLE 4 (Continued)
Outcome Evidence Statement Qualityb References
TCCs seem more effective than therapeutic
footwear to heal a neuropathic plantar heel
DFUa
SURROGATE
Plantar pressure TCCs and removable knee-high offloading devices
are equally effective in reducing peak pressure at
the DFU location and forefoot and rearfoot
areas.
Moderate Gutekunst et al 2011,55 Gotz et al
2017,95 Armstrong et al 1999,96
Fleischli et al 1997,97 and Lavery
et al 199698
Removable knee-high offloading devices are more
effective in reducing peak pressure at the DFU
location and forefoot area than removable ankle-
high offloading devices
Moderate Bus et al 2018,16 Crews et al 2018,27
Westra et al 2018,46 Gotz et al
2017,95 Crews et al 2012,99 Nagel
and Rosenbaum 2009,100 and
Fleischli et al 199797
Removable ankle-high offloading devices seem
more effective than conventional or standard
therapeutic footwear in reducing plantar
pressure at the DFU location and forefoot areas
Low Crews et al 2018,27 Gotz et al
2017,95 Bus et al 2017,101 Crews
et al 2012,99 Raspovic et al
2012,102 Bus et al 2009103 Bus
et al 2009,104 Nagel and
Rosenbaum 2009,100 and Fleischli
et al 199797
Therapeutic footwear seems more effective than
conventional footwear in reducing peak pressure
at forefoot areas
Low Viswanathan et al 2004,79 Nouman
et al 2017,105 Lin et al 2013,106
Kavros et al 2011,107 Guldemond
et al 2007,108 Praet et al 2003,109
Raspovic et al 2000,110 Lavery et al
1997,111 Lavery et al 1997,112
Lavery et al 1996,98 and Kato et al
1996113
Botulinum toxin injections are not superior to
saline placebo injections for reducing plantar
pressure at forefoot areas
Moderate Hastings et al 201266
Felted foam applied to the forefoot with a cut out
to the ulcer area seems more effective at
reducing plantar pressure over 1 week compared
with no felted foam
Low Pabon-Carrasco et al 2016114 and
Raspovic et al 201637
Achilles tendon lengthening in addition to a TCC
seems more effective at reducing peak pressures
at the forefoot in the short term than a TCC
alone, but not in the long term, and at the
expense of increases in rearfoot peak pressure.
Low Maluf et al 200470
Ulcer area TCCs and non-removable knee-high walkers are
equally effective to reduce DFU area
Moderate Piaggesi et al 201619
Nonremovable knee-high offloading devices and
removable knee-high offloading devices seem
equally effective to reduce DFU area
Low Najafi et al 2017,18 Piaggesi et al
2016,19 and Caravaggi et al 200759
Nonremovable knee-high offloading devices and
removable ankle-high offloading devices seem
equally effective to reduce DFU area
Low Chakraborty et al 2015,54 Strakhova
et al 2014,73 Faglia et al 2010,56
Van de Weg et al 2008,58 Agas
et al 2006,74 and Udovichenko
et al 200675
Removable knee-high offloading devices and
removable ankle-high offloading devices are
equally effective to reduce DFU area
Moderate Bus et al 201816 and Johnson et al
201833
Felted foam attached to the foot (changed every
3 days) and worn in a removable ankle-high
offloading device seems more effective to
Low Zimny et al 200368
(Continues)
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TABLE 4 (Continued)
Outcome Evidence Statement Qualityb References
reduce DFU area than a removable ankle-high
offloading device only
Felted foam attached to the foot and worn in a
removable ankle-high offloading device seems
equally effective to reduce DFU area as
attaching the felted foam to the insole of the
removable ankle-high offloading device
Low Nube et al 200667
Ambulatory activity Nonremovable knee-high offloading devices and
removable knee-high offloading devices seem to
be associated with similar reductions in
ambulatory activity
Low Najafi et al 2017,18 Lavery et al
2015,34 and Armstrong et al
200163
Nonremovable knee-high offloading devices are
associated with a greater reduction in
ambulatory activity than removable ankle-high
offloading devices
Moderate Lavery et al 201534 and Armstrong
et al 200163
Removable knee-high offloading devices seem to
be associated with greater reductions in
ambulatory activity than removable ankle-high
offloading devices
Low Bus et al 2018,16 Lavery et al 2015,34
and Armstrong et al 200163
Adherence Nonremovable knee-high offloading devices are
associated with higher adherence than
removable offloading devices.
Low Lavery et al 201534 and Ha Van et al
200376
Removable knee-high offloading devices and
removable ankle-high devices seem to be
associated with similar levels of adherence.
Low Bus et al 201816 and Johnson et al
201833
SECONDARY
Adverse events Nonremovable offloading devices and removable
offloading devices seem to be associated with
similar proportions of adverse events.
Low Health Quality Ontario 2017,12 Lewis
and Lipp 2013,52 Najafi et al
2017,18 Piaggesi et al 2016,19
Lavery et al 2015,34 Faglia et al
2010,56 Van de Weg et al 2008,58
Caravaggi et al 2007,59 Piaggesi
et al 2007,60 Armstrong et al
2005,61 Katz et al 2005,62 and
Armstrong et al 200163
TCCs and non-removable knee-high walkers seem
to be associated with similar proportions of
adverse events
Low Health Quality Ontario 2017,12
Piaggesi et al 2016,19 Piaggesi et al
2007,60 and Katz et al 200562
Removable knee-high and removable ankle-high
offloading devices seem to be associated with
similar proportions of adverse events.
Low Health Quality Ontario 2017,12 Bus
et al 2018,16 Lavery et al 2015,34
and Armstrong et al 200163
Nonremovable knee-high offloading devices and
therapeutic footwear seem to be associated with
similar proportions of adverse events.
Low Health Quality Ontario 2017,12
Miyan et al 2014,36 Ganguly et al
2008,57 Caravaggi et al 2000,64
and Mueller et al 198965
Felted foam (with an aperture cut to the DFU
location) attached to either the foot or the insole
in a removable ankle-high offloading device (and
changed every few days) seems to be associated
with similar proportions of adverse events as
only wearing a removable ankle-high offloading
device
Low Nube et al 200667 and Zimny et al
200368
Custom-made light-weight fibreglass heel cast in
addition to usual care seems to be associated
with similar proportions of adverse events as
Low Jeffcoate et al 201717
(Continues)
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3.1 | Primary outcome: DFU healing
3.1.1 | Non-removable offloading devices
PICO a
In people with a plantar DFU, are non-removable offloading devices
compared with removable offloading devices effective to heal the DFU?
Summary of the evidence. We identified five meta-analyses (one with
very low risk of bias52 and the other four with low risk of bias12,13,15,53)
and one additional controlled study (NRCT with high risk of bias73) not
included in those meta-analyses. All studies primarily reported on
patients with a neuropathic plantar forefoot or midfoot DFU. As each
of the five meta-analyses included a different combination of studies
out of a total 14 controlled studies (12 RCTs and two other controlled
studies, with seven we assessed as having [very] low
TABLE 4 (Continued)
Outcome Evidence Statement Qualityb References
using usual care alone in patients with
neuropathic rearfoot DFUa
Botulinum toxin injections and saline placebo
injections seem to be associated with similar
proportions of adverse events
Low Hastings et al 201266
Achilles tendon lengthening in addition to a TCC
seems to be associated with more adverse
events (particularly new heel ulcers) than using a
TCCs alone.
Low Mueller et al 200371
Metatarsal head resection(s) in addition to non-
surgical offloading interventions seems to be
associated with fewer adverse events
(particularly new infections) than non-surgical
offloading alone in patients with neuropathic
plantar metatarsal DFUa
Low Kalantar Motamedi et al 2017,80
Armstrong et al 2012,82 Armstrong
et al 2005,61 and Piaggesi et al
199872
Patient-reported outcomes Nonremovable knee-high offloading devices,
removable knee-high offloading devices,
removable ankle-high offloading devices and
therapeutic footwear seem to be associated with
similar patient-reported outcomes.
Low Piaggesi et al 2016,19 Lavery et al
2015,34 Piaggesi et al 2007,60 and
Caravaggi et al 200064
Custom-made light-weight fibreglass heel cast in
addition to usual care seems to be associated
with similar patient-reported outcomes as using
usual care alone in patients with a neuropathic
rearfoot DFUa
Low Jeffcoate et al 201717
Metatarsal head resection(s) in addition to non-
surgical offloading interventions seems to be
associated with better patient-reported
outcomes than non-surgical offloading alone in
patients with neuropathic plantar metatarsal
DFUa
Low Piaggesi et al 199872
Cost-effectiveness Nonremovable knee-high offloading devices seems
to be more cost-effective than removable
offloading devices in healing the DFU
Low Health Quality Ontario 2017,12
Piaggesi et al 2016,19 and Faglia
et al 201056
Nonremovable knee-high walkers are more cost-
effective than TCCs in healing the DFU
Moderate Health Quality Ontario 2017,12
Piaggesi et al 201619 Piaggesi et al
2007,60 and Katz et al 200562
Removable knee-high walkers seem to be more
cost-effective than therapeutic footwear in
healing the DFU
Low Health Quality Ontario 201712
Custom-made light-weight fibreglass heel cast in
addition to usual care seems to be equally cost-
effective as using usual care alone in patients
with a neuropathic rearfoot DFUa
Low Jeffcoate et al 201717
Abbreviations: DFU, diabetes-related foot ulcer; TCC, total contact cast.
aUlcer type that is not specifically a neuropathic plantar forefoot or midfoot ulcers in patients with diabetes.
bQuality: Quality of the evidence.
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risk19,55,56,58,60,61,76 and seven with high risk of bias18,34,59,63-65,74), we
will discuss each meta-analysis separately. We did not separately dis-
cuss the NRCT as it did not add to the evidence obtained from the
meta-analyses and does not change our evidence statement.73
The most recent meta-analysis by Health Quality Ontario
reported two analyses for healing rates.12 First, they included six RCTs
(three [very] low risk,19,55,56 three high risk of bias34,59,63) with a
cumulative total of 274 patients and found a significant risk difference
(RD) to achieve healing at 3 months of 0.17 (95% confidence interval
[CI], 0.00-0.33; P = .05) in favour of non-removable offloading using
the total contact cast (TCC) compared with a removable knee-high
walker.12 Second, they included three RCTs (two low risk,19,61 one
high risk of bias18) with a cumulative total of 141 patients, and found
a significant risk difference to achieve healing at 3 months of 0.21
(95% CI, 0.01-0.40; P = .04) in favour of using a non-removable knee-
high walker compared with a removable knee-high walker.12
The second meta-analysis by Elraiyah et al included four RCTs
(three at low risk,56,58,60 one at high risk of bias63) with a cumulative
total of 162 patients and reported healing rate and time-to-healing.13
For healing rate, they included three of those RCTs56,58,63 with a
cumulative total of 122 patients and reported a non-significant rela-
tive risk (RR) to achieve healing of 1.15 (95% CI 0.92-0.1.45;
P = 0.217) in favour of non-removable offloading (TCC) compared
with removable offloading devices (knee-high walker or custom-made
temporary footwear).13 For time-to-healing they included all four
RCTs and reported a significant mean difference in healing time of
−12.36 days (95% CI, −22.63 to −2.09; P = .018) in favour of non-
removable compared with removable offloading devices using the
same definitions.13
The third meta-analysis by Martins de Oliveira and Moore included
seven RCTs (four at low risk,56,58,60,61 three at high risk of bias63-65)
with a cumulative total of 350 patients and reported healing rate and
time-to-healing.15 For healing rate, they reported a significant odds ratio
(OR) to achieve healing of 0.31 (95% CI, 0.19-0.52; P < .001) in favour
of non-removable offloading (TCC or non-removable knee-high walker)
compared with removable offloading (knee-high walker, forefoot
offloading shoe, felted foam, or therapeutic footwear).15 For time-to-
healing, they included six of those RCTs56,58,60,61,63,65 with a cumulative
total of 300 patients and reported a significant mean difference in
healing time of −8.14 days (95% CI, −9.51 to −6.77; P < .001) also in
favour of non-removable offloading compared with removable
offloading device using the same definitions.15
The fourth meta-analysis by Morona et al included eight
RCTs55,56,58,59,61,63-65 and two other controlled studies74,76 (five at
[very] low risk,55,56,58,61,76 five at high risk of bias59,63-65,74) with a
cumulative total of 524 patients and reported healing rates.53 They
found a significant RR to achieve healing of 1.43 (95% CI, 1.11-1.84;
P = 0.001) in favour of non-removable offloading (TCC or non-remov-
able walkers) compared with removable offloading (removable walker
or therapeutic footwear).53 When comparing non-removable
offloading (TCC or non-removable walker) with removable offloading
(walker only) in five RCTs (three at [very] low risk,55,56,61 two at high
risk of bias59,63), with a cumulative total of 220 patients, they found a
non-significant RR to achieve healing of 1.23 again in favour of non-
removable offloading (95% CI, 0.96-1.58; P = .085).53
The oldest meta-analysis with very low risk of bias by Lewis and
Lipp included five RCTs (three at low risk,56,60,61 two at high risk of
bias59,63) with a cumulative total of 230 patients and reported healing
rate.52 They found a significant RR to achieve healing of 1.17 (95% CI,
1.01-1.36; P = .04) in favour of non-removable offloading (TCC or
non-removable walker) compared with removable offloading (walker
or therapeutic footwear).52
Evidence statement. Nonremovable knee-high offloading devices are
more effective than removable offloading devices to heal a neuro-
pathic plantar forefoot or midfoot DFU.
Quality of evidence (QoE). High: Based on five meta-analyses (all low or
very low risk of bias)—that included 14 controlled studies (7 at [very]
low risk of bias, 7 at high risk of bias)—all with consistent results.
References. Health Quality Ontario 2017,12 Elraiyah et al 2016,13 Mar-
tins de Oliveira and Moore 2015,15 Morona et al 2013,53 and Lewis
and Lipp 2013.52
PICO b
In people with a plantar DFU, are TCCs compared with other non-
removable knee-high offloading devices effective to heal the DFU?
Summary of the evidence. We identified two meta-analyses12,53 and
four RCTs.19,36,60,62 All studies primarily reported on patients with a
neuropathic plantar forefoot or midfoot DFU. As the more recent
meta-analysis12 included three of those four RCTs,19,60,62 and two of
those RCTs60,62 were included in the older meta-analysis,53 we only
report the more recent meta-analysis12 and the RCT36 not included in
either meta-analysis.
The meta-analysis by Health Quality Ontario, with low risk of
bias, included three RCTs (all low risk of bias19,60,62) with a cumulative
total of 126 patients.12 They found a non-significant risk difference to
achieve healing between TCCs and non-removable knee-high walkers
of 0.02 (95% CI, −0.11 to 0.14; P = .82).12 The additional RCT with
high risk of bias allocated 70 patients into three groups: TCC, non-
removable walker, and modified footwear.36 They found no difference
between TCC and non-removable walker for healing rates (95.0% vs
94.7%; P = .99) and time-to-healing (45.0 vs 46.0 days; P = .767)36.
Evidence statement. TCCs and non-removable knee-high walkers are
equally effective to heal a neuropathic plantar forefoot or
midfoot DFU.
QoE. Moderate: Based on two meta-analysis with low risk of bias—
that included three RCTs with low risk of bias—and another RCT with
high risk of bias, all with consistent results. However, as none of the
RCTs was powered for equivalence, we downgraded to moderate.
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References. Health Quality Ontario 2017,12; Morona et al 2013,53 and
Miyan et al 2014.36
3.1.2 | Removable offloading devices
PICO
In people with a plantar DFU, are removable knee-high offloading
devices compared with other removable offloading devices effective
to heal the DFU?
Summary of the evidence. We identified one meta-analysis12 and three
RCTs.16,34,63 All studies primarily reported on patients with a neuro-
pathic plantar forefoot or midfoot DFU.
The meta-analysis by Health Quality Ontario, with low risk of
bias, included two RCTs with high risk of bias34,63 with a cumulative
total of 100 patients.12 It found a non-significant risk difference to
achieve healing between removable knee-high walker and removable
ankle-high devices (post-operative healing sandal or half-shoe) of
−0.13 (95% CI, −0.31 to 0.06; P = .19).12
The RCT not included in the meta-analysis, with very low risk of
bias, randomised 60 patients into a removable bivalved TCC, a remov-
able cast shoe, and a removable forefoot offloading shoe.16 The
authors found no significant differences between the three groups for
healing rate at 12 weeks (58% vs 60% vs 70%, respectively; P = .703)
or 20 weeks (63% vs 83% vs 80%, respectively; P = .305). However,
participants with the bivalved TCC had more deep ulcers (University
of Texas Grade 2A) at baseline (50% vs 30% vs 15%, respectively),
which was significantly different compared with the forefoot
offloading shoe (P = .043),16 and had more dropouts at 12 weeks
(35% vs 0% vs 15%, respectively), which was significantly different
compared with the cast shoe (P = .011).
Evidence statement. Removable knee-high offloading devices and
removable ankle-high offloading devices are equally effective to heal
a neuropathic plantar forefoot or midfoot DFU.
QoE. Moderate: Based on one meta-analysis with low risk of bias—
that included two RCTs with high risk of bias—and another RCT with
very low risk of bias, all with consistent results. However, as no study
was powered for equivalence, we downgraded to moderate.
References. Health Quality Ontario 2017,12 and Bus et al.16
3.1.3 | Footwear
PICO
In people with a plantar DFU, are conventional or standard therapeu-
tic footwear compared with other (non-surgical) offloading interven-
tions effective to heal the DFU?
Summary of the evidence. We identified three meta-analyses with low
risk of bias12,13,53 and one RCT with high risk of bias36 not included in
those meta-analyses. All meta-analyses compared “therapeutic foot-
wear” with a non-removable offloading device (a TCC or non-remov-
able walkers). All studies primarily reported on patients with a
neuropathic plantar forefoot or midfoot DFU. However, studies
defined “therapeutic footwear” as being either custom-made or
customised footwear with or without insoles and/or ankle-high
removable offloading devices (forefoot offloading shoes, post-
operative healing shoes). Whereas we define therapeutic footwear as
only being custom-made or customised footwear with or without
insoles. Thus, we only report the meta-analyses where the majority of
included RCTs defined therapeutic footwear according to our defini-
tion. We identified no controlled studies comparing conventional or
therapeutic footwear with removable offloading devices.
The most recent meta-analysis by Health Quality Ontario
included five RCTs (four at high risk,34,63-65 one at low risk of bias58)
with a cumulative total of 229 patients.12 They found a significant risk
difference to achieve healing of 0.25 (95% CI, 0.04-0.46; P = .02) in
favour of non-removable offloading (TCCs) compared with therapeu-
tic footwear.12 The second meta-analysis by Elraiyah et al included
two RCTs (both at high risk of bias57,65) with a cumulative total of
98 patients13 and found a non-significant RR to achieve healing of
1.76 (95% CI, 0.77-4.02, P = .184) in favour of non-removable
offloading (TCC) compared with “conventional dressings” (dressings,
plus, extra-depth footwear with plastazote insole65 or custom-made
footwear57).13 The third meta-analysis by Morona et al included six
controlled studies (three RCTs at high risk of bias,63-65 one RCT at low
risk,58 one cohort at low risk,76 one cohort at high risk of bias74) with
a cumulative total of 318 patients.53 They found a significant RR to
achieve healing of 1.68 (95% CI, 1.09-2.58, P = .004) in favour of non-
removable offloading devices (either TCC or walkers rendered non-
removable) compared with therapeutic footwear.53
The additional RCT with high risk of bias randomised 70 patients
into three groups: TCC, non-removable walker, or modified foot-
wear36 and found no difference for healing rates (95.0% vs 94.7% vs
95.7%; P = .99) and time-to-healing (45.0 vs 46.0 vs 34.0 days;
P = .767) between interventions.36
Evidence statement. Therapeutic footwear is less effective than non-
removable knee-high offloading devices to heal a neuropathic plantar
forefoot or midfoot DFU.
QoE. Moderate: Based on three meta-analyses all with low risk of
bias—that included nine controlled studies (seven at high risk, two at
low risk of bias)—all with consistent results, except for the smallest
meta-analysis which was non-significant but potentially underpow-
ered. One additional RCT with high risk of bias also showed no dif-
ferences. Thus, with some minor inconsistencies, we downgraded to
moderate.
References. Health Quality Ontario 2017,12 Elraiyah et al 2016,13 Mor-
ona et al 2013,53 and Miyan et al 2014.36
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3.1.4 | Other offloading techniques
PICO
In people with a plantar DFU, are other (non-surgical) offloading tech-
niques that are not device- or footwear-related, effective to heal a DFU?
Summary of the evidence. We identified two controlled studies (one
RCT at high risk of bias,68 one cohort study at high risk of bias77) with
both reporting on the use of felted foam. No controlled studies were
identified that reported on bed rest, crutches, walking sticks/canes,
wheelchairs, offloading dressings, callus debridement, or foot-related
exercises to heal DFUs.
The RCT with high risk of bias randomised 54 patients into two
groups: one received felted foam with an aperture cut to the exact
location of the DFU attached to the foot (changed every third day)
and worn in an ankle-high post-operative shoe, and the other an
ankle-high pressure relief half shoe.68 They found a significantly
shorter time-to-healing in the felted foam group (75 vs 85 days;
P = .02) but did not report healing rates.68 The cohort study with
high risk of bias retrospectively investigated 120 patients in four
groups: TCC, non-removable walking splint, felt pad with cut-out to
ulcer attached to the forefoot worn in a wedged-soled ankle-high
post-operative shoe, and felt pad with cut-out to ulcer attached to
the wedged-soled post-operative shoe.77 They reported similar ulcer
healing rates after 12 weeks (92% vs 83% vs 93% vs 81%, respec-
tively; P > .05) and time-to-healing (47.4 vs 50.5 vs 36.1 vs
41.4 days; P value not reported).77 Also, after adjusting for ulcer
depth and width, they found time-to-healing was not significantly
different between groups (31.7 vs 38.2, 20.9, and 32.7 days;
P > .05).77
Evidence statement. Felted foam (with an aperture cut to the DFU
location) attached to either the foot or the insole in a removable
ankle-high offloading device seems to be more effective to heal
the DFU than only wearing a removable ankle-high offloading
device.
QoE. Low: Based on one RCT with high risk of bias and small effect
size, and one retrospective cohort study with high risk of bias, we
downgraded to low.
References. Zimny et al 200368 and Birke et al 2002.77
3.1.5 | Surgical offloading techniques
PICO
In people with a plantar DFU, are surgical offloading techniques compared
with non-surgical offloading interventions effective to heal the DFU?
The evidence for this category will be discussed according to the
specific surgical intervention.
Achilles tendon lengthening
Summary of the evidence. We identified one meta-analysis with very
low risk of bias14 and four additional non-controlled studies.115-118
The meta-analysis by Dallimore and Kaminski included two RCTs (one
at low risk of bias on Achilles tendon lengthening71 and one at high
risk of bias on Gastrocnemius recession as identified and quality
assessed by the meta-analysis)119) with a cumulative total of
92 patients.14 They compared surgical offloading interventions
(Achilles tendon lengthening or Gastrocnemius recession in combina-
tion with TCCs) with non-removable offloading devices (TCC only)
and found a non-significant difference in risk ratio to achieve healing
of 1.06 (95% CI, 0.94-1.20; P = .34) and non-significant mean differ-
ence in time-to-healing of 8.22 days (95% CI, −18.99 to 34.43 days;
P = .55) between interventions.14 Four non-controlled retrospective
studies investigated Achilles tendon lengthening, after unsuccessful
healing with an offloading device (TCC or removable walker), in
patients with reduced ankle dorsiflexion range of motion.115-118 They
found 91% to 93% of plantar forefoot ulcers healed with Achilles ten-
don lengthening in a mean of 6 to 12 weeks.115-118
Evidence statement. Achilles tendon lengthening in addition to a non-
removable offloading device seems equally effective to heal a neu-
ropathic plantar forefoot or midfoot DFU as a non-removable
offloading device alone.
QoE. Low: Based on one meta-analysis with very low risk of bias—that
included two RCTs (one at low risk, one at high risk of bias)—all show-
ing non-significant differences. However, as the meta-analysis may be
underpowered to detect a statistical difference and none of the RCTs
was powered for equivalence, we downgraded to low.
References. Dallimore and Kaminski 2015.14
Metatarsal head resection
Summary of the evidence. We identified four controlled studies (one
RCT with low risk of bias,72 one cohort with low risk of bias,82 and
two other cohort studies with high risk of bias80,83).
The RCT with low risk of bias randomised 41 patients with plan-
tar forefoot ulcers to metatarsal head resection (a combination of sur-
gical techniques [excision, debridement, removal of bone segments
underlying the lesion and surgical closure] in combination with conser-
vative offloading [therapeutic footwear with insoles]) or conservative
offloading alone (therapeutic footwear with insoles).72 They showed
significantly higher healing rates (95% vs 79%; P < .05) and shorter
time-to-healing (47 vs 130 days; P < .05) in the surgical offloading
group.72
The cohort study with low risk of bias retrospectively evaluated
92 patients with metatarsal head ulcers and found those treated with
metatarsal head resections in combination with conservative
offloading (removable walker or healing sandal) had significantly faster
time-to-healing than those treated with conservative offloading alone
(removable walker or healing sandal) (60.1 vs 84.2 days; P = .003).82 A
cohort study with high risk of bias retrospectively evaluated
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40 participants with plantar metatarsal head ulcers and found those
treated with metatarsal head resection had significantly improved
healing rates (100% vs 60%; P = .001) and time-to-healing (37 vs
384 days; P < .001) compared with those treated with conservative
offloading (“non-weight-bearing, and, sometimes, specialized foot-
wear”).80 The final cohort study with high risk of bias retrospectively
evaluated 50 patients with plantar fifth metatarsal head ulcers and
found that fifth metatarsal head resection in combination with
conservative offloading (removable walker) had significantly better
time-to-healing than conservative offloading alone (removable walker)
(5.8 vs 8.7 weeks; P = .02).83
Evidence statement. Metatarsal head resection(s) in combination with
a removable offloading device seems more effective to heal a neuro-
pathic plantar metatarsal head DFU than using a removable offloading
device alone.
QoE. Low: Based primarily on three cohort studies (two with high risk
and one low risk of bias) and one RCT with low risk, all with consistent
results.
References. Kalantar Motamedi et al 2017,80 Armstrong et al 2012,82
Armstrong et al 2005,83 and Piaggesi et al 1998.72
Joint arthrodesis
Summary of the evidence. We identified one RCT with high risk of bias
randomising 21 patients with midfoot plantar ulcers associated with
Charcot deformity to extended medial column arthrodesis in combina-
tion with TCC or to TCC alone and found similar time-to-healing
(24 vs 26 days; P > .05).69
Evidence statement. Medial column arthrodesis in combination with a
non-removable offloading device is not superior in healing a neuro-
pathic plantar midfoot DFU associated with a Charcot deformity than
using a non-removable offloading device alone.
QoE. Low: Based on one small RCT with high risk of bias and not
powered for equivalence, we downgraded to low.
References.Wang et al 2015.69
Joint arthroplasty
Summary of the evidence.We identified two retrospective cohort stud-
ies with high risk of bias.84,85 The first retrospectively evaluated
41 patients and found a significant improvement in time-to-healing in
the surgical group (first metatarsal phalangeal joint arthroplasty in
combination with non-removable walker) compared with non-remov-
able walker alone (24 vs 67 days; P = .0001).84 The second retrospec-
tively evaluated 29 patients and found no difference in healing rate
(100% vs 100%), but quicker time-to-healing (23 vs 47 days; P value
not reported) in the surgical group (arthroplasty of the first proximal
phalanx combined with TCC) compared with TCC alone, but did not
report on statistical signficance.85
Evidence statement. First metatarsal-phalangeal joint arthroplasty in
combination with a non-removable offloading device may lead to
shorter time-to-healing a neuropathic plantar hallux DFU than using a
non-removable offloading device alone.
QoE. Low: Based on two retrospective cohort studies with high risk of
bias and inconsistent results.
References. Armstrong et al 200384 and Lin et al 2000.85
Osteotomy
Summary of the evidence. We identified one retrospective cohort
study with high risk of bias.81 The study retrospectively evaluated
22 patients treated with subtraction osteotomy for a metatarsal head
ulcer to redress bone axis and arthrodesis with staples compared with
54 patients receiving conservative treatment (offloading not defined)
and found significantly shorter time-to-healing in the surgical group
(51 vs 159 days; P = .004).81
Evidence statement. Osteotomy seems more effective to heal a meta-
tarsal head DFU than conservative treatment (with or without
offloading) alone.
Quality of evidence. Low: Based on one retrospective cohort study
with high risk of bias that did not define the control offloading
treatment.
References. Vanlerberghe et al 2014.81
Digital flexor tenotomy
Summary of the evidence. We identified eight retrospective non-con-
trolled case series with a cumulative total of 369 patients, treated
with percutaneous digital flexor tenotomy to heal apical toe ulcers,
reporting a 92% to 100% healing rate with a mean time-to-healing of
13 to 40 days.86-93
Evidence statement. Digital flexor tenotomy seems effective to heal a
neuropathic plantar lesser digit apical DFU, but evidence from con-
trolled studies is needed to confirm this.
QoE. Low: Based on eight retrospective case series all reporting con-
sistent results.
References. Engels et al 2016,86 Tamir et al 2014,87 Rasmussen et al
2013,88 van Netten et al 2013,89 Kearney et al 2010,90 Schepers et al
2010,91 Tamir et al 2008,92 and Laborde et al 2007.93
Other surgical offloading procedures
Summary of the evidence. We identified multiple other non-controlled
studies reporting on other surgical offloading procedures. Four non-
controlled studies found relatively high percentages (74%-100%) of
healing after exostectomy in patients with rigid, prominent deformi-
ties secondary to Charcot's neuro-osteoarthropathy.120-123
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Otherwise, other selected surgical procedures reported in non-
controlled case series, and typically performed in patients with
complex plantar soft tissue defects (with or without infection), may
have value in promoting ulcer healing in selected cases. These
surgical offloading techniques included using free flaps,124,125
Achilles tenotomy,126 flexor hallucis tendon transfer,127,128 plantar
fascia release,129 calcanectomy,130-132 and surgical reconstruction133
or external fixation134-136 of Charcot deformity, or a combination
of these procedures (resection, tendon transfer, and
reconstruction).137,138
Evidence statement. None.
3.1.6 | Other DFU types
PICO a
In people with a plantar DFU complicated by infection or ischaemia,
which offloading intervention is effective to heal the DFU?
Summary of the evidence. We identified nine controlled stud-
ies17,33,58,65,67,75,76,80,81 and two large prospective non-controlled
studies31,94 on offloading interventions that either did not exclude or
specifically included participants with DFUs that were complicated by
infection and/or ischaemia at baseline. None of the controlled studies
specifically reported on the healing rates of subgroups of patients
with DFUs complicated by infection or ischaemia at baseline, but the
two non-controlled studies did.
The most recent non-controlled study prospectively compared
the healing rates of a cohort of 177 patients with different sub-
groups of DFU that were treated with a non-removable offloading
device (windowed TCC).31 They found no difference in healing
after a mean of 96 days between those with uncomplicated
(no infection or ischaemia) neuropathic DFU at baseline and those
complicated with moderate ischaemia or those immediately post-
surgery to resolve osteomyelitis with/without clinical signs of
infection (“operated osteomyelitis”) (84% vs 81% vs 71%, respec-
tively; P > .1).31
The second non-controlled study prospectively compared the
healing rates of a cohort of 98 patients with different subgroups
of DFUs that were treated with three different offloading devices
and all instructed to not remove their cast between wound care
visits: 50 with a TCC, 22 with a bivalved TCC, and 26 with a non-
removable cast shoe.94 They found no differences between the
healing rates of the three different offloading devices; however,
the rates and P values were not reported.94 They found no differ-
ence in collective healing rates between uncomplicated DFU and
mildly infected neuropathic DFU (90% vs 87%; P > .05).94 How-
ever, they did find a difference between uncomplicated DFU, DFU
complicated with moderate ischaemia, and DFU with both moder-
ate ischaemia and mild infection (90% vs 69% vs 36%, respec-
tively; P < .01).94
Evidence statement. Nonremovable knee-high offloading devices seem
effective to heal a neuropathic plantar forefoot DFU complicated by
either mild infection or mild ischaemia.
QoE. Low: Based on two large prospective non-controlled studies, one
reporting only on outcomes of non-removable knee-high offloading
devices and the other predominantly.
References. Ha Van et al 201531 and Nabuurs-Franssen et al 2005.94
PICO b
In people with a plantar rearfoot DFU, which offloading intervention
is effective to heal the DFU?
Summary of the evidence. We identified two RCTs (one at very low
risk,17 one at high risk of bias57) that included participants with DFUs
on the plantar rearfoot. However, only one of these RCTs specifically
reported on the healing rates of subgroups of patients with plantar
rearfoot DFUs.57 This RCT with high risk of bias randomised 58 patients
with DFU to either a TCC or therapeutic footwear and found shorter
time-to-healing in the TCC group within the subgroup of 16 patients
with plantar rearfoot DFU (69 vs 107 days; p = not reported).57
Evidence statement. TCCs seem more effective than therapeutic foot-
wear to heal a neuropathic plantar heel DFU.
QoE. Low: Based on one RCT with high risk of bias that found clinical
difference but did not report statistical difference, we downgraded
to low.
References. Ganguly et al 2008.57
PICO c
In people with a non-plantar DFU, which offloading intervention is
effective to heal the DFU?
Summary of the evidence. We identified one large RCT with very low
risk of bias.17 This RCT randomised 509 patients, most (72%) with a
non-plantar rearfoot DFU, to receive either a custom-made, light-
weight, fibreglass heel cast with usual care or usual care alone.17 They
found no differences between the two groups for healing rate after
24 weeks (44% vs 37%; P = .088); however, although most ulcers
were non-plantar, they did not perform subgroup analyses of the out-
comes for specific non-plantar heel ulcer locations.17 No studies were
identified on other non-plantar DFU locations.
Evidence statement. None. Although there was one large RCT, we
were unable to provide an evidence statement as the RCT did not
specifically report on non-plantar DFU outcomes.
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3.2 | Surrogate outcome: Plantar pressure
Outcomes for plantar pressure, mostly peak pressure, were obtained dur-
ing walking barefoot or in a device or shoe, unless otherwise reported.
PICO
In people with a plantar DFU, which offloading intervention reduces
plantar pressure most effectively?
We identified five controlled trials,16,55,66,70,79 and 29 non-con-
trolled studies,26,27,37,46,95-114,139-143 addressing this clinical question for
non-removable offloading devices, removable offloading devices, foot-
wear, other offloading techniques, and surgical offloading.
3.2.1 | Non-removable offloading devices
Summary of the evidence. We identified one RCT55 and multiple cross-
sectionals studies.95-98 The RCT with very low risk of bias randomised
23 patients to a non-removable knee-high device (TCC) or removable
knee-high offloading device (walker).55 They found compared with
baseline barefoot plantar pressures, a significantly greater reduction in
plantar pressures in the removable knee-high walker compared with
the TCC at the ulcer area (91% vs 80%; P = .024), forefoot (92% vs
84%; P = .011), and midfoot (77% vs 63%; P = 0.036), but no difference
at the rearfoot (40% vs 54%; P = .108) or for the total foot (77% vs
73%; P = .297).55
Four cross-sectional studies found TCCs and different removable
knee-high walkers (DH pressure relief walkers, aircast walkers, 3D
walkers, CAM walkers, and Vaco diaped walkers) produced similar
mean peak pressures reductions from conventional footwear pressure
baselines at different regions of the forefoot (ulcer site, hallux, medial
metatarsal heads, lateral metatarsal head).95-98 Findings in the
rearfoot, however, were mixed with one study showing TCCs had
greater peak pressure reduction96 and another showing removable
knee-high walkers had greater peak pressure reduction.95
Three other cross-sectional studies investigated the effect of
modified TCCs.26,46,139 One found a modified TCC (bivalved TCC)
reduced significantly less peak pressure than a standard TCC at the
hallux (108 vs 57 kPa; P < .05) and midfoot (104 vs 77 kPa; P < .05)
but had similar peak pressures in other regions of the forefoot and
rearfoot (all, P > .05).46 Another study found a modified TCC (with
12-mm Poron insole) reduced significantly more peak pressure at the
ulcer area than the standard TCC using canvas shoe baseline values
(70% vs 44%; P < .01).139 The last study found that a modified TCC
(ankle-high) reduced significantly less peak pressure than a standard
knee-high TCC at the forefoot (13% difference) and midfoot (8%)
(P < .05), but the same for the rearfoot (2%) (P > .05).26
Evidence statement. TCCs and removable knee-high offloading devices
are equally effective in reducing peak pressure at the DFU location
and forefoot and rearfoot areas.
QoE. Moderate: Based on one small RCT with very low risk of bias
showing small effects in favour of removable knee-high walkers, plus
four cross-sectional studies showing no differences but using different
types of devices, we downgraded to moderate.
References. Gutekunst et al 2011,55 Gotz et al 2017,95 Armstrong et al
1999,96 Fleischli et al 1997,97 and Lavery et al 1996.98
3.2.2 | Removable offloading devices
Summary of the evidence. We identified one RCT16 and multiple cross-
sectional studies.27,46,95,97,99-104 The RCT with very low risk of bias
tested plantar pressure reductions after 2 weeks in a subsample of
34 patients randomised to different removable offloading devices.16
Compared with the patient's own footwear, a bivalved TCC reduced
peak pressure at the ulcer area more effectively than a cast shoe and
forefoot offloading shoe (67% vs 26% and 47%, respectively;
P = .029).16
Six cross-sectional studies found different types of removable
knee-high devices (DH pressure relief walkers, aircast walkers, 3D
walkers, CAM walkers, Vaco diaped walkers, and bivalved TCCs) to be
significantly more effective in reducing forefoot peak pressure than
removable ankle-high devices (walkers, cast shoes, half-shoes, postop-
erative shoes),27,46,95,97,99,100 with two studies also reporting signifi-
cantly lower rearfoot peak pressures in the knee-high devices.95,100
Nine cross-sectional studies also found different types of remov-
able ankle-high offloading devices (walkers, cast shoes, half-shoes,
postoperative shoes, forefoot offloading shoes, pressure relief shoe)
to be significantly more effective in reducing forefoot peak pressure
compared with different footwear types (extra-depth footwear, can-
vas shoes, sneaker, off-the-shelf footwear, athletic shoe, standard
shoe),27,95,97,99-104 with four studies also finding significantly lower
rearfoot plantar pressures in the ankle-high devices.100,101,103,104
Evidence statement a. Removable knee-high offloading devices are
more effective in reducing peak pressure at the DFU and forefoot
area than removable ankle-high offloading devices.
QoE. Moderate: Based on one RCT with very low risk of bias and six
cross-sectional studies all with consistent results, but all using differ-
ent types of devices, we have downgraded to moderate.
References. Bus et al 2018,16 Crews et al 2018,27 Westra et al 2018,46
Gotz et al 2017,95 Crews et al 2012,99 Nagel et al 2009,100 Fleischli
et al 1997.97
Evidence statement b. Removable ankle-high offloading devices seem
more effective than conventional or standard therapeutic footwear in
reducing peak pressure at the DFU location and forefoot areas.
QoE. Low: Based on nine cross-sectional studies, all with consistent
results.
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References. Crews et al 2018,27 Gotz et al 2017,95 Bus et al 2017,101
Crews et al 2012,99 Raspovic et al 2012,102 Bus et al 2009,103 Bus
et al 2009,104 Nagel et al 2009,100 and Fleischli et al 1997.97
3.2.3 | Footwear
Summary of the evidence. We identified one prospective cohort
study79 and multiple cross-sectional studies.98,105-113 The prospective
cohort study with high risk of bias allocated 241 patients with DFU
history (previous or current) to four different footwear types. They
found after 9 months follow-up that three different therapeutic foot-
wear groups (two groups with different customised sandals and one
group customised footwear) had significant reductions in in-shoe peak
pressures at their metatarsal heads (57.4% vs 62.0% vs 58.0%, respec-
tively) compared with baseline, but another group wearing their own
conventional sandals had significant increases in peak pressures
(+39.4%) (all, P < .01).79
Nine cross-sectional studies found different types of therapeutic
footwear (custom-made, extra-depth shoes, rocker-bottom shoes,
custom-made insoles/orthoses) reduce forefoot peak pressure more
effectively than conventional footwear (canvas shoes, walking shoes,
athletic shoes).98,105-113
Evidence statement. Therapeutic footwear seems more effective than
conventional footwear in reducing peak pressure at forefoot areas in
people with diabetes.
QoE. Low: Based on one controlled study with high risk bias and
10 cross-sectional studies all with consistent results.
References. Viswanathan et al 2004,79 Nouman et al 2017,105 Lin et al
2013,106 Kavros et al 2011,107 Guldemond et al 2007,108 Praet et al
2003,109 Raspovic et al 2000,110 Lavery et al 1997,111 Lavery et al
1997,112 Lavery et al 1996,98 and Kato et al 1996.113
3.2.4 | Other offloading techniques
Summary of the evidence. We identified one RCT on botulinum toxin66
and five non-controlled studies on additional other offloading tech-
niques, including felted foam,37,114 offloading dressing,140 and bio-
feedback gait retraining sessions.141,142 The RCT with very low risk of
bias randomised 17 patients with a neuropathic plantar forefoot ulcer
to receive injections of either botulinum toxin (200- or 300-unit
doses) or saline into the medial and lateral gastrocnemius and soleus
muscle bellies of the limb with the ulcer. The authors found no differ-
ences between groups on plantar pressure reductions at baseline or
after 2 weeks.66
Two cross-sectional studies investigated felted foam.37,114 The
first found felted foam of different densities applied to the foot signif-
icantly reduced forefoot peak pressure during barefoot walking, both
immediately after application (57%-72%, P < .05) and after 72 hours
(48%-72%, P < .05).114 The second found deflective felted foam
applied to the barefoot and worn in a post-operative shoe reduced
peak pressure at the ulcer site significantly more effectively than a
post-operative shoe alone, both immediately after application (49%)
and after 7 days wear (32%) (P < .05).37
One cross-sectional study found a 38% reduction in peak pressure at
the ulcer site immediately after the application of an adhesive polyure-
thane foam wound dressing compared with no foam dressing (P < .01).140
Two non-controlled prospective studies investigated the effect of
biofeedback gait retraining.141,142 This involved measuring patient's
in-shoe plantar pressure at baseline and then encouraging patients to
practice changing their gait until they were able to demonstrate a
40% to 80% reduction in peak plantar pressure at their ulcer
area.141,142 Both studies retested patients after 10 days and found
significant decreases in peak pressure at the ulcer site compared with
baseline (P < .05): 20% in the first study142 and 31% in the second.141
Evidence statement a. Botulinum toxin injections are not superior to
saline placebo injections for reducing plantar pressure at forefoot
areas in persons with neuropathic plantar forefoot ulcers.
QoE.Moderate: Based on one small RCT with very low risk of bias not
powered for equivalence, we downgraded to moderate.
References. Hastings et al 2012.66
Evidence statement b. Felted foam applied to the forefoot with a cut
out to the ulcer area seems more effective at reducing plantar pres-
sure over 1 week at the DFU site compared with using no
felted foam.
QoE. Low: Based on two cross-sectional studies with consistent
findings.
References. Pabon-Carrasco et al 2016114 and Raspovic et al 2016.37
Evidence statement c. No evidence statements for wound dressings or
biofeedback gait retraining were justified due to limited evidence.
3.2.5 | Surgical offloading techniques
Summary of the evidence. We identified one RCT70 and one non-con-
trolled study.143 The RCT with low risk of bias70 tested plantar pres-
sure reductions in a subsample of a larger RCT on Achilles tendon
lengthening.71 They randomised 28 participants to have Achilles ten-
don lengthening in addition to a TCC (surgical group) or TCC alone
(control group) and measured peak pressures at baseline immediately
prior to treatment, and 3 weeks and 8 months post-treatment.70 They
found no differences between groups at baseline (P > .05), but signifi-
cantly lower forefoot peak pressures and higher rearfoot peak pres-
sures in the surgical group at 3 weeks, of which the differences in
rearfoot peak pressure remained at 8 months (P < .005).70 The non-
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controlled study of people with neuropathic plantar forefoot ulcers
found peak plantar pressure reductions at the metatarsal heads fol-
lowing metatarsal head resections.143
Evidence statement. Achilles tendon lengthening in addition to a TCC
seems more effective at reducing peak pressures at the forefoot in
the short term than a TCC alone, but not in the long term, and at the
expense of increases in rearfoot peak pressure.
QoE. Low: Based on one small RCT with low risk of bias, but because
it was a subsample of a larger RCT and not powered for this outcome,
we downgraded to low.
References.Maluf et al 2004.70
4 | DISCUSSION
In this updated systematic review on offloading interventions to heal
DFUs, we identified six meta-analyses, 26 RCTs, 13 other controlled
studies, and 120 non-controlled studies. New studies included since
our previous review 4 years ago were four of those meta-analyses,
seven RCTs, two other controlled studies, and 28 non-controlled stud-
ies. The methodological quality of the studies varied, with six meta-
analyses, 13 RCTs, and two other controlled studies being high quality
([very] low risk of bias), and the rest of lower quality. Most studies
investigated the effects of offloading devices, including five meta-ana-
lyses, 19 RCTs, and six other controlled studies. Therefore, for
offloading devices, we were able to formulate relatively strong evi-
dence statements where the quality of supporting evidence was typi-
cally moderate to high. However, studies investigating other
interventions were limited in both number and quality, such as for
footwear, surgical offloading, and other offloading techniques. There-
fore, for these offloading intervention categories, we were either
unable to formulate any evidence statements or were only able to for-
mulate weaker evidence statements based on limited supporting evi-
dence. Otherwise, virtually no evidence existed in several other
important areas, including offloading interventions to heal DFU that
were non-plantar, on the plantar rearfoot or complicated by infection
or ischaemia.
4.1 | Non-removable offloading devices
There is strong evidence, supported by five high-quality meta-
analyses,12,13,15,52,53 that non-removable knee-high offloading
devices heal plantar forefoot and midfoot ulcers more effectively
and at faster rates than all other offloading interventions. Further
strong evidence demonstrates that (non-removable and removable)
knee-high offloading devices more effectively reduce plantar pres-
sure at the ulcer site16,27,46,95 and non-removable knee-high
offloading devices give significantly higher adherence levels34,76,144
than other removable offloading devices and therapeutic footwear.
We found some evidence that they may also result in similar or
reduced ambulatory activity levels to removable knee-high
devices18,34,63 and removable ankle-high devices.34,63 These find-
ings support the superiority of non-removable knee-high offloading
devices in healing DFUs.
Although evidence clearly shows the healing benefits, non-
removable knee-high offloading devices have also been believed to
result in more adverse events than other offloading interventions.
However, the available evidence, although not substantial, does not
seem to support these beliefs. There is some evidence that non-
removable knee-high offloading devices result in similar adverse
events12,52 and patient-reported satisfaction levels to that of remov-
able offloading devices or therapeutic footwear.19,34,60,64 There is also
some evidence that non-removable offloading devices are more cost-
effective than removable offloading devices and therapeutic
footwear.12,19,56
From the different non-removable knee-high offloading devices
available, we again identified11 that TCCs and non-removable walkers
are equally effective.12,36,53 They are equally effective to heal
DFU12,36,53 and reduce plantar pressure.55,95-98 We also found some
evidence they produced similar levels of adverse events12 and patient
satisfaction.19,34,60 However, we did find that non-removable walkers
were more cost-effective than TCCs.12,19,60,62 Therefore, the available
evidence base clearly demonstrates that patients with neuropathic
plantar forefoot or midfoot ulcers should be provided with either a
TCC or non-removable knee-high walker as their first choice of
offloading treatment.
4.2 | Removable offloading devices
We found relatively strong evidence that removable knee-high and
ankle-high offloading devices are equally effective to heal plantar
forefoot or midfoot ulcers and reduce ulcer surface area.12,16 How-
ever, we also found relatively strong evidence that removable knee-
high offloading devices are more effective at reducing plantar pres-
sure at the forefoot16,27,46,95,97,99,100 and some evidence they also
reduce ambulatory activity to a larger extent16,34,63 than removable
ankle-high offloading devices and therapeutic footwear. On the other
hand, evidence suggests patients may be less adherent to wearing
removable knee-high than ankle-high offloading devices.16,34 These
findings on surrogate outcomes may counteract each other to explain
why these devices result in similar healing outcomes, as identified in
one high-quality RCT.16 Therefore, more effective healing in remov-
able knee-high offloading devices may be achievable if improved
patient adherence levels can be assured.28
Nonremovable knee-high offloading devices are sometimes contra-
indicated and may not be preferred by clinicians and patients.145-147
From our findings, removable offloading devices are the next best
evidence-based option for DFU offloading. However, it should be noted
that many different types of removable knee-high and ankle-high
offloading devices have been tested, and no single type of removable
device seems superior to another which further complicates the
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decision on which removable offloading device to use in clinical prac-
tice. Therefore, we recommend that future RCTs compare the effective-
ness of more homogenous types of removable devices, such as custom-
made vs prefabricated or knee-high vs above ankle-high vs below
ankle-high, against gold standard non-removable knee-high offloading
devices and each other. This would better inform clinicians and patients
on the removable offloading devices that are most (cost-)effective for
healing, preferred by patients, limit adverse events, and encourage
adherence.
4.3 | Footwear
We found strong evidence that conventional and therapeutic footwear is
much less effective to heal a plantar forefoot or midfoot DFU,12,13,36,53
reduce plantar pressure at the ulcer site,27,95,97,99-104 and much less cost-
effective than (non)removable knee-high offloading devices.12
Furthermore, we found some evidence that they produced similar levels
of adverse events12 and patient satisfaction64 to (non)removable
offloading devices. In addition, therapeutic footwear is less effective at
reducing plantar pressure than removable ankle-high offloading
devices27,95,97,99-104 but more effective than conventional foot-
wear.79,98,105-113 As a result of these findings, conventional or therapeutic
footwear should not be used to heal a plantar forefoot or midfoot DFU
as there are more effective offloading device interventions available.
4.4 | Other non-surgical offloading techniques
While other non-surgical offloading techniques are commonly used in
clinical practice for offloading plantar DFU,145-147 such as the use of
crutches and bed rest, the current evidence is virtually non-existent
for these practices. We only identified studies on the effects of felted
foam, offloading wound dressings, biofeedback gait retraining, and
botulinum toxin injections. We found some evidence that felted foam
can be more effective in healing a plantar DFU68,77 than not using
felted foam, either by attaching it to the foot or to the insole of a
removable ankle-high device.67,77 The basis for this seems be a more
effective reduction of plantar pressure with using felted foam than
without.37,114 Similar effects on pressure were also shown for a foam
wound dressing,140 and for biofeedback gait retraining sessions,141,142
but all only show effects over the following days and long-term
effects are unknown. Limited evidence also showed there is no bene-
fit for botulinum toxin injections over placebo saline injections to
reduce plantar pressures.66 Clearly, more high-quality controlled stud-
ies are needed to increase the evidence bases for these other non-
surgical offloading interventions.
4.5 | Surgical offloading techniques
The current evidence base for surgical offloading for healing plantar
DFU is still limited, with very few controlled studies published69,80
since our previous review 4 years ago.11 Achilles tendon lengthening
seems to have limited value in addition to a TCC alone in healing plan-
tar forefoot ulcers.14 However, there is some evidence it reduces
forefoot plantar pressure in the short term, but at the expense of
increased rearfoot plantar pressure resulting in more new heel ulcer
adverse events than when using a TCC alone.70 The evidence also
indicates that most other surgical procedures do not improve the pro-
portion of healed ulcers, only the time-to-healing. This includes meta-
tarsal head resections72,80,82,83 and joint arthroplasty.84,85 We found
some promising effects for digital flexor tenotomy to heal plantar
lesser digit DFU in multiple case series,86-93 but there are no con-
trolled studies to confirm this as yet. It should be noted that all these
surgical offloading studies either included patients that had failed to
heal using offloading devices, tested procedures that were used in
combination with offloading devices, and/or showed effects com-
pared with a comparator that was not considered a gold standard
non-surgical offloading treatment. As we identified 4 years ago, high-
quality controlled studies, preferably multi-centred RCTs,30 are still
needed to further define the role of surgical offloading interventions
compared with non-surgical offloading treatments.
4.6 | Other DFU types
Nearly all evidence found in this systematic review was on the efficacy
of offloading interventions to heal neuropathic plantar forefoot and
midfoot DFU without infection and ischaemia. We found some evi-
dence for the use of non-removable knee-high offloading devices to
heal plantar forefoot DFU complicated by mild infection or mild ischae-
mia.31,94 Similarly, we found some evidence for the use of non-remov-
able knee-high offloading devices to heal plantar rearfoot DFU.57
However, no specific evidence was found for the use of offloading
interventions to heal non-plantar DFU, although these ulcers also
require offloading to heal. As neuropathic foot ulcers that are compli-
cated by infection or ischaemia or are located on the non-plantar sur-
face currently represent a large proportion of DFU seen in clinical
practice,148 we repeat our conclusion from 4 years ago that the
evidence-base for the use of offloading to heal these other types of
DFU types requires urgent expansion through high-quality controlled
studies to inform the community on effective treatment for these DFU.
4.7 | Key considerations
There are several key considerations that come out of this updated
systematic review.
First, new evidence from this review is making it increasingly clear
that patient adherence levels to wearing offloading devices heavily
influences the effectiveness of ulcer healing. Even the best offloading
device will not be effective if not worn. Conversely, removable
devices seem to be as effective as non-removable devices when worn.
While non-removable devices may be one solution to increasing
adherence, these devices are sometimes contraindicated or not
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preferred by clinicians. Therefore, ways to encourage patients to
adhere should receive immediate attention by clinicians and
researchers. Offering more attractive personalised offloading treat-
ments and improving the motivation of patients to the benefits on
healing of wearing their devices may help in this regard.
Second, the available evidence identified from this review almost
exclusively focuses on noncomplicated neuropathic plantar forefoot
and midfoot ulcers. Little evidence exists on the efficacy to heal
non-plantar ulcers, rearfoot plantar ulcers, and ulcers complicated by
infection or ischaemia, even though such ulcers are very common,
particularly in the case of peripheral artery disease. High-quality RCTs
on foot ulcers other than neuropathic plantar forefoot and midfoot
ulcers are urgently needed to better inform clinicians about effective
offloading treatments for such ulcers.
Third, we acknowledge the challenges inherent in the design of
RCTs involving surgical offloading procedures, including regional vari-
ations in equipment, technique, and practice, and that surgical inter-
vention is often a last resort intervention employed after failed
healing with non-surgical offloading interventions. For these reasons,
we accept that other study designs investigating foot ulcer healing by
surgical offloading may be suitable as well. However, we do note with
interest that a protocol for a high-quality RCT on surgical offloading
has recently been published.30
Fourth, in this updated review, we specifically assessed for a
range of surrogate and secondary outcomes. This has illustrated that
compared with the primary outcome of healing little evidence exists
for the effect of offloading interventions on ambulatory activity,
adherence, adverse events, patient-reported, and cost outcomes. We
recommend that future controlled trials report these outcomes in
alignment with international definition standards.24 This should pro-
vide more details on how these surrogate outcomes influence healing,
which may enable the development of new offloading interventions
that are better tailored to improve these outcomes and with that,
healing. Additionally, as RCTs often do not adequately power for sec-
ondary outcomes, this would facilitate future meta-analyses on these
outcomes, particularly for adverse events, such as pre-ulcerative
lesions, new ulcers, and falls24.
Fifth, we note there are no known objective thresholds for surro-
gate outcomes that indicate improved chances of DFU healing.6
Whereas, in the field of DFU prevention, there are certain thresholds
for peak plantar pressures that have been shown to reduce risk of re-
ulceration,149,150 no such thresholds yet exist for DFU healing. We
recommend that trials interrogate their surrogate outcome data to
explore if such thresholds for plantar pressure, ambulatory activity,
adherence, or a combination exist to better inform the field on how
much offloading is needed to improve healing.44
Sixth, although this review has identified broad categories of
removable offloading devices that positively affect healing, removable
offloading devices are made up of a large variety of custom-made and
prefabricated devices, different foot device interfaces, heights, and
other features, such as rocker bottoms. Future trials should determine
which specific devices or designs are most effective for offloading and
improving healing.
Last, most studies in this review come from economically devel-
oped countries with relatively mild temperate climates. There is a
need for more studies on optimal approaches to ulcer healing in less
economically developed countries and those where climate may be a
factor in adherence to, or efficacy of, treatment. This may involve the
development of offloading devices that are lighter in weight, provide
a cooler environment, and are less expensive than some of the devices
currently on the market, without losing the key mechanical features
that optimise offloading and healing.
5 | CONCLUSIONS
Our updated systematic review shows that the evidence base to sup-
port the use of offloading interventions to heal DFU has improved
substantially in several areas over the last few years but is still small
or non-existent in other areas. By far, the best available evidence is
for the use of non-removable knee-high offloading devices, either
TCC or walkers rendered non-removable, for the healing of neuro-
pathic plantar forefoot and midfoot ulcers. Additionally, high-quality
recent evidence supports the use of different removable offloading
devices to heal plantar forefoot and midfoot ulcers when patients
adhere to wearing them and it does not support the use of conven-
tional or therapeutic footwear. The evidence bases to support the use
of other non-surgical offloading interventions and the use of surgical
offloading is still weak. Likewise, the evidence bases to support the
use of any offloading interventions to heal non-plantar foot ulcers,
plantar rearfoot ulcers, and ischaemic or infected neuropathic ulcers is
practically non-existent. High-quality RCTs of non-surgical and surgi-
cal offloading interventions that include measures for changes in plan-
tar pressure, ambulatory activity, and treatment adherence (where
appropriate), as well as reporting of adverse events, patient satisfac-
tion, and costs, are needed to better inform clinicians and patients
about effective offloading treatment in these areas.
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